US4107288A
(en)
|
1974-09-18 |
1978-08-15 |
Pharmaceutical Society Of Victoria |
Injectable compositions, nanoparticles useful therein, and process of manufacturing same
|
DE3369355D1
(en)
*
|
1983-10-19 |
1987-02-26 |
Sulzer Ag |
Vibration isolating and damping support for a loom
|
CA2024697A1
(en)
|
1989-09-07 |
1991-03-08 |
George P. Vlasuk |
Protein having anticoagulant properties
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
IL102758A
(en)
|
1991-08-23 |
1997-03-18 |
Akzo Nv |
Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
|
ZA928276B
(en)
|
1991-10-31 |
1993-05-06 |
Daiichi Seiyaku Co |
Aromatic amidine derivates and salts thereof.
|
JP3194953B2
(ja)
|
1992-02-14 |
2001-08-06 |
コルバス・インターナショナル、インコーポレイテッド |
血栓症抑制剤
|
ATE177752T1
(de)
|
1992-12-15 |
1999-04-15 |
Corvas Int Inc |
Neue inhibitoren von faktor xa
|
CA2155931C
(en)
|
1993-02-12 |
2002-11-19 |
George Phillip Vlasuk |
Inhibitors of thrombosis
|
US5563127A
(en)
|
1993-03-24 |
1996-10-08 |
The Dupont Merck Pharmaceutical Company |
Boronic acid and ester inhibitors of thrombin
|
US5656600A
(en)
|
1993-03-25 |
1997-08-12 |
Corvas International, Inc. |
α-ketoamide derivatives as inhibitors of thrombosis
|
US5863534A
(en)
|
1993-04-09 |
1999-01-26 |
Bio-Technology General Corp. |
Polypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activity
|
JP3388803B2
(ja)
|
1993-05-20 |
2003-03-24 |
第一製薬株式会社 |
光学活性7−アミジノナフタレン誘導体の製造法
|
SE9301916D0
(sv)
|
1993-06-03 |
1993-06-03 |
Ab Astra |
New peptides derivatives
|
US5681844A
(en)
|
1994-04-18 |
1997-10-28 |
Corvas International, Inc. |
Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
|
NZ284977A
(en)
|
1994-04-26 |
1998-09-24 |
Selectide Corp |
Factor xa enzyme inhibitor
|
US5561146A
(en)
|
1994-06-10 |
1996-10-01 |
Bristol-Myers Squibb Company |
Modified guanidino and amidino thrombin inhibitors
|
US5633381A
(en)
|
1994-07-05 |
1997-05-27 |
Berlex Laboratories, Inc. |
(Z,Z), (Z,E) and (E,Z) isomers of substituted bis(phenylmethylene)cycloketones
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
ES2276396T3
(es)
|
1994-10-18 |
2007-06-16 |
Dendreon Corporation |
Proteinas anticoagulantes e inhibidores de la serina proteasa extraidos de nematodos.
|
SE504185C2
(sv)
|
1994-11-08 |
1996-12-02 |
Astra Ab |
Lagringsstabil vattenlösning för infusion av trombininhibitorer
|
KR100383161B1
(ko)
|
1994-12-02 |
2003-12-24 |
야마노우치세이야쿠 가부시키가이샤 |
신규한아미디노나프틸유도체또는이의염
|
SE9404196D0
(sv)
|
1994-12-02 |
1994-12-02 |
Astra Ab |
New antithrombotic formulation
|
US5656645A
(en)
|
1994-12-13 |
1997-08-12 |
Corvas International, Inc. |
Aromatic heterocyclic derivatives as enzyme inhibitors
|
NZ298699A
(en)
|
1994-12-13 |
2001-03-30 |
Corvas Int Inc |
3-amino-1,2-dihydropyrid-1-yl(and 5-amino-1,6-dihydro-6-oxo(and 5,6-dioxo)pyrimidin-1-yl)-acetyl-argininal derivatives, useful for the treatment of blood coagulation and thrombosis
|
US5658930A
(en)
|
1994-12-13 |
1997-08-19 |
Corvas International, Inc. |
Aromatic heterocyclic derivatives as enzyme inhibitors
|
US6025472A
(en)
|
1994-12-21 |
2000-02-15 |
Corvas International, Inc. |
N-substituted glycine derivatives as enzyme inhibitors
|
ATE252100T1
(de)
|
1995-02-27 |
2003-11-15 |
Hoffmann La Roche |
Dioxopyrrolo-pyrrolderivate
|
DK0813525T3
(da)
|
1995-03-10 |
2004-02-16 |
Berlex Lab |
Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
|
US5639739A
(en)
|
1995-03-24 |
1997-06-17 |
The Dupont Merck Pharmaceutical Company |
Imidazole containing aminoboronic acids
|
US5612363A
(en)
|
1995-06-02 |
1997-03-18 |
Berlex Laboratories, Inc. |
N,N-di(aryl) cyclic urea derivatives as anti-coagulants
|
US5612378A
(en)
|
1995-06-06 |
1997-03-18 |
3-Dimensional Pharmaceuticals, Inc. |
Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
|
US5741819A
(en)
|
1995-06-07 |
1998-04-21 |
3-Dimensional Pharmaceuticals, Inc. |
Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
|
US5721214A
(en)
|
1995-06-07 |
1998-02-24 |
Cor Therapeutics, Inc. |
Inhibitors of factor Xa
|
US5612353A
(en)
|
1995-06-07 |
1997-03-18 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
|
US6069130A
(en)
|
1995-06-07 |
2000-05-30 |
Cor Therapeutics, Inc. |
Ketoheterocyclic inhibitors of factor Xa
|
US5919765A
(en)
|
1995-06-07 |
1999-07-06 |
Cor Therapeutics, Inc. |
Inhibitors of factor XA
|
US6034093A
(en)
|
1995-06-07 |
2000-03-07 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
|
US5731315A
(en)
|
1995-06-07 |
1998-03-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds
|
GB9515489D0
(en)
|
1995-07-28 |
1995-09-27 |
Sandoz Ltd |
Organic compounds
|
DE19530996A1
(de)
|
1995-08-23 |
1997-02-27 |
Boehringer Mannheim Gmbh |
Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel
|
HUP9802764A3
(en)
|
1995-09-29 |
2000-03-28 |
Dimensional Pharm Inc |
Guanidino protease inhibitors
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
DE69623038T2
(de)
|
1995-12-20 |
2002-12-12 |
Aventis Pharma Inc |
Verfahren zur herstellung von n-acetyl(l)-4-cyanophenylalanin ac-(l)-phe(4-cn)-phe(4-cn)-oh und n-acetyl-(l)-p-amidinophenylalanin-cyclohexylglycin-beta-(3-n-methylpyridinium)-alanin ac-(l)-paph-chg-palme(3)-nh2
|
AR005245A1
(es)
|
1995-12-21 |
1999-04-28 |
Astrazeneca Ab |
Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
|
WO1997023212A1
(en)
|
1995-12-21 |
1997-07-03 |
The Du Pont Merck Pharmaceutical Company |
ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
|
IL124883A0
(en)
|
1995-12-29 |
1999-01-26 |
Dimensional Pharm Inc |
Amidino protease inhibitors and pharmaceutical compositions containing the same
|
SI0906094T1
(sl)
|
1996-01-02 |
2003-12-31 |
Aventis Pharmaceuticals Inc. |
Substituirani N-/(aminoiminometil ali aminometil)fenil/propil amidi
|
US6080767A
(en)
|
1996-01-02 |
2000-06-27 |
Aventis Pharmaceuticals Products Inc. |
Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
GB9602294D0
(en)
|
1996-02-05 |
1996-04-03 |
Zeneca Ltd |
Heterocyclic compounds
|
US5994375A
(en)
|
1996-02-12 |
1999-11-30 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
|
TR199801569T2
(xx)
|
1996-02-13 |
1998-10-21 |
Akzo Nobel N.V. |
Serin proteaz inhibit�rleri.
|
ES2186874T3
(es)
|
1996-02-22 |
2003-05-16 |
Bristol Myers Squibb Pharma Co |
Analogos de m-amidinofenilo como inhibidores del factor xa.
|
CA2250426C
(en)
|
1996-03-29 |
2006-05-02 |
3-Dimensional Pharmaceuticals, Inc. |
Amidinohydrazones as protease inhibitors
|
DE19612828C1
(de)
|
1996-03-30 |
1997-02-27 |
Boehringer Mannheim Gmbh |
Verfahren zur Herstellung von Naphthonitrilderivaten und deren Verwendung zur Herstellung von Faktor-Xa-Inhibitoren
|
FR2754260B1
(fr)
*
|
1996-10-04 |
1998-10-30 |
Adir |
Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
IL126610A0
(en)
|
1996-04-17 |
1999-08-17 |
Du Pont Pharm Co |
N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
|
SE9601556D0
(sv)
|
1996-04-24 |
1996-04-24 |
Astra Ab |
New pharmaceutical formulation of a thrombin inhibitor for parenteral use
|
SE9602145D0
(sv)
|
1996-05-31 |
1996-05-31 |
Astra Ab |
New improved formulation for treatment of thromboembolism
|
HU224315B1
(hu)
|
1996-06-05 |
2005-07-28 |
Gyógyszerkutató Intézet Kft. |
Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
|
HU222199B1
(hu)
|
1996-06-05 |
2003-05-28 |
Gyógyszerkutató Intézet Kft. |
Véralvadásgátló hatású peptid-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
|
JPH101467A
(ja)
|
1996-06-13 |
1998-01-06 |
Banyu Pharmaceut Co Ltd |
ビフェニルアミジン誘導体
|
US6124291A
(en)
|
1996-06-18 |
2000-09-26 |
Warner-Lambert Company |
Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
|
CA2253835A1
(en)
|
1996-06-18 |
1997-12-24 |
Kent Alan Berryman |
Process for the preparation of chiral keto-heterocycles of basic amino acids
|
US6200967B1
(en)
|
1996-06-25 |
2001-03-13 |
Eli Lilly And Company |
Anticoagulant agents
|
JPH1017549A
(ja)
|
1996-07-02 |
1998-01-20 |
Banyu Pharmaceut Co Ltd |
二環性芳香族アミジン誘導体
|
AU3645697A
(en)
|
1996-07-08 |
1998-02-02 |
Du Pont Pharmaceuticals Company |
Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of factor xa and of thrombin
|
WO1998006694A1
(en)
|
1996-08-16 |
1998-02-19 |
Du Pont Pharmaceuticals Company |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
|
US5753635A
(en)
|
1996-08-16 |
1998-05-19 |
Berlex Laboratories, Inc. |
Purine derivatives and their use as anti-coagulants
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
US6057342A
(en)
|
1996-08-16 |
2000-05-02 |
Dupont Pharmaceutical Co. |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
|
WO1998009987A1
(en)
|
1996-09-06 |
1998-03-12 |
Biochem Pharma, Inc. |
Lactam inhibitors of thrombin
|
KR20000036017A
(ko)
|
1996-09-12 |
2000-06-26 |
에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 |
시클릭 아미노산 및 시클릭 히드록시산 유도체로 치환된 벤즈아
|
US6004985A
(en)
|
1996-10-09 |
1999-12-21 |
Berlex Laboratories, Inc. |
Thio acid derived monocylic N-heterocyclics as anticoagulants
|
US6369080B2
(en)
|
1996-10-11 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
EP0937073A2
(en)
|
1996-10-11 |
1999-08-25 |
Cor Therapeutics, Inc. |
Selective factor xa inhibitors
|
JP2001502674A
(ja)
|
1996-10-11 |
2001-02-27 |
シーオーアール・セラピューティックス・インコーポレーテッド |
選択的Xa因子阻害物質
|
WO1998016547A1
(en)
|
1996-10-11 |
1998-04-23 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
SE9603724D0
(sv)
|
1996-10-11 |
1996-10-11 |
Astra Ab |
New pharmaceutical parenteral formulation of a thrombin inhibitor
|
WO1998016524A1
(en)
|
1996-10-11 |
1998-04-23 |
Cor Therapeutics, Inc. |
HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS
|
UA56197C2
(uk)
|
1996-11-08 |
2003-05-15 |
Зенека Лімітед |
Гетероциклічні похідні
|
EP0842941A1
(de)
|
1996-11-16 |
1998-05-20 |
Roche Diagnostics GmbH |
Neue Phosphonate, Verfahren zu ihrer Herstellung und Arzneimittel
|
US6602864B1
(en)
|
1996-12-13 |
2003-08-05 |
Aventis Pharma Deutschland Gmbh |
Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
|
KR20000057528A
(ko)
|
1996-12-13 |
2000-09-25 |
오흘러 로스 제이. |
설폰산 또는 설포닐아미노 n-(헤테로아르알킬)-아자헤테로사이클릴아미드 화합물
|
JP2001506271A
(ja)
|
1996-12-23 |
2001-05-15 |
デュポン ファーマシューティカルズ カンパニー |
Xa因子阻害剤としての酸素またはイオウを含む複素環式芳香族化合物
|
PL334250A1
(en)
|
1996-12-23 |
2000-02-14 |
Du Pont Pharm Co |
Nitrogen containing hetero-aromatic compounds and inhibitors of xa factor
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
TW542822B
(en)
|
1997-01-17 |
2003-07-21 |
Ajinomoto Kk |
Benzamidine derivatives
|
JP2001521524A
(ja)
|
1997-04-14 |
2001-11-06 |
シーオーアール セラピューティクス インコーポレイテッド |
選択的Xa因子阻害剤
|
NZ500352A
(en)
|
1997-04-14 |
2001-10-26 |
Cor Therapeutics Inc |
Cyclic diaza selective factor Xa inhibitors
|
NZ500353A
(en)
|
1997-04-14 |
2002-02-01 |
Cor Therapeutics Inc |
Cyclic diaza compounds that are selective inhibitors of factor Xa
|
AU747531B2
(en)
|
1997-04-14 |
2002-05-16 |
Millennium Pharmaceuticals, Inc. |
Selective factor Xa inhibitors
|
JP2001525823A
(ja)
|
1997-05-15 |
2001-12-11 |
イーライ・リリー・アンド・カンパニー |
抗血栓化合物
|
CA2287292A1
(en)
|
1997-05-30 |
1998-12-03 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, their production and use
|
TW513402B
(en)
|
1997-05-30 |
2002-12-11 |
Daiichi Seiyaku Co |
Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives
|
US20010046974A1
(en)
|
1997-06-06 |
2001-11-29 |
Hamilton Civic Hospitals Res Dev., Inc. |
Modified low molecular weight heparin that inhibits clot associated coagulation factors
|
DE69830403T2
(de)
|
1997-06-19 |
2006-02-02 |
Bristol-Myers Squibb Pharma Co. |
Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität
|
ZA985247B
(en)
|
1997-06-19 |
1999-12-17 |
Du Pont Merck Pharma |
Guanidine mimics as factor Xa inhibitors.
|
AU7976998A
(en)
|
1997-06-19 |
1999-01-04 |
Du Pont Merck Pharmaceutical Company, The |
(amidino)6-membered aromatics as factor xa inhibitors
|
US6060491A
(en)
|
1997-06-19 |
2000-05-09 |
Dupont Pharmaceuticals |
6-membered aromatics as factor Xa inhibitors
|
US6339099B1
(en)
|
1997-06-20 |
2002-01-15 |
Dupont Pharmaceuticals Company |
Guanidine mimics as factor Xa inhibitors
|
US6417200B1
(en)
|
1997-06-26 |
2002-07-09 |
Eli Lilly And Company |
Antithrombotic agents
|
ES2241151T3
(es)
|
1997-06-26 |
2005-10-16 |
Eli Lilly And Company |
Agentes antitromboticos.
|
IL133621A0
(en)
|
1997-06-26 |
2001-04-30 |
Lilly Co Eli |
Antithrombotic agents
|
EP0999834B1
(en)
|
1997-06-26 |
2005-10-12 |
Eli Lilly And Company |
Antithrombotic agents
|
AU735144B2
(en)
|
1997-07-23 |
2001-07-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel hexahydro-1,4-diazepine derivatives or their salts
|
GB9715895D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic compounds
|
GB9715894D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic derivatives
|
JP2001512742A
(ja)
|
1997-08-11 |
2001-08-28 |
シーオーアール セラピューティクス インコーポレイテッド |
選択的Xa因子阻害剤
|
EP0994894A1
(en)
|
1997-08-11 |
2000-04-26 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
CA2299612A1
(en)
|
1997-08-11 |
1999-02-18 |
Cor Therapeutics, Inc. |
Selective factor xa inhibitors containing a fused azepinone structure
|
US5886191A
(en)
|
1997-08-18 |
1999-03-23 |
Dupont Pharmaceuticals Company |
Amidinoindoles, amidinoazoles, and analogs thereof
|
WO1999010316A1
(fr)
|
1997-08-27 |
1999-03-04 |
Kissei Pharmaceutical Co., Ltd. |
Derives de 3-amidinoaniline, inhibiteurs du facteur x de coagulation sanguine activee, et intermediaires de production de ces derives et de ces inhibiteurs
|
US6740682B2
(en)
|
1997-08-29 |
2004-05-25 |
Tularik Limited |
Meta-benzamidine derivatives as serine protease inhibitors
|
EP1012166B1
(en)
|
1997-08-29 |
2003-10-29 |
Tularik Limited |
1-amino-7-isoquinoline derivatives as serine protease inhibitors
|
AU8886698A
(en)
|
1997-09-01 |
1999-03-22 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel naphthamide derivatives or salts thereof
|
EP1015429B1
(en)
|
1997-09-09 |
2004-05-12 |
Bristol-Myers Squibb Pharma Company |
Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
|
GB9719161D0
(en)
|
1997-09-09 |
1997-11-12 |
Glaxo Group Ltd |
New therapeutic method
|
KR20010015639A
(ko)
|
1997-09-30 |
2001-02-26 |
스즈키 다다시 |
술포닐 유도체
|
DE19743435A1
(de)
|
1997-10-01 |
1999-04-08 |
Merck Patent Gmbh |
Benzamidinderivate
|
US6693075B1
(en)
|
1997-10-23 |
2004-02-17 |
Regents Of The University Of Minnesota |
Modified vitamin K-dependent polypeptides
|
JPH11140040A
(ja)
|
1997-11-06 |
1999-05-25 |
Kissei Pharmaceut Co Ltd |
3−アミジノフェニルエーテル誘導体、活性化血液凝固第x因子阻害剤およびそれらの製造中間体
|
IL126893A
(en)
|
1997-11-19 |
2003-05-29 |
Akzo Nobel Nv |
Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
|
JPH11152269A
(ja)
|
1997-11-20 |
1999-06-08 |
Teijin Ltd |
ビフェニルアミジン誘導体
|
AU736112B2
(en)
|
1997-11-20 |
2001-07-26 |
Teijin Limited |
Biphenylamidine derivatives
|
HUP0100085A3
(en)
|
1997-11-20 |
2002-12-28 |
Teijin Ltd |
Biphenylamidine derivatives and pharmaceutical compositions containing them
|
PL340560A1
(en)
|
1997-11-26 |
2001-02-12 |
Dimensional Pharmaceuticals 3 |
Heteroaryl aminoguanidines and alkoxyguanidines and their application as protease inhibitors
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
WO1999026932A1
(en)
|
1997-11-26 |
1999-06-03 |
Axys Pharmaceuticals, Inc. |
By amidino group substituted heterocyclic derivatives and their use as anticoagulants
|
WO1999026933A1
(en)
|
1997-11-26 |
1999-06-03 |
Axys Pharmaceuticals, Inc. |
Substituted amidinoaryl derivatives and their use as anticoagulants
|
SE9704400D0
(sv)
|
1997-11-28 |
1997-11-28 |
Astra Ab |
Porous inorganic particles as carriers for drug substances
|
SE9704401D0
(sv)
|
1997-11-28 |
1997-11-28 |
Astra Ab |
Matrix pellets for greasy, oily or sticky drug substances
|
US6686364B2
(en)
|
1997-12-08 |
2004-02-03 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
DE19755268A1
(de)
|
1997-12-12 |
1999-06-17 |
Merck Patent Gmbh |
Benzamidinderivate
|
US6140351A
(en)
|
1997-12-19 |
2000-10-31 |
Berlex Laboratories, Inc. |
Ortho-anthranilamide derivatives as anti-coagulants
|
EP1040108B1
(en)
|
1997-12-19 |
2004-02-25 |
Schering Aktiengesellschaft |
Ortho-anthranilamide derivatives as anti-coagulants
|
EP1042299A1
(en)
|
1997-12-22 |
2000-10-11 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
US6271237B1
(en)
|
1997-12-22 |
2001-08-07 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
|
CA2316172C
(en)
|
1997-12-24 |
2010-02-02 |
Aventis Pharma Deutschland Gmbh |
Indole derivatives as inhibitors of factor xa
|
AU1689999A
(en)
|
1997-12-25 |
1999-07-19 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
AU1692399A
(en)
|
1997-12-26 |
1999-07-19 |
Mochida Pharmaceutical Co., Ltd. |
Aromatic compounds having cyclic amino or salts thereof
|
FR2773801B1
(fr)
|
1998-01-19 |
2000-05-12 |
Sanofi Sa |
Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
|
WO1999037643A1
(fr)
|
1998-01-26 |
1999-07-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouveaux derives heterocycliques a fusion benzenique ou sels de ceux-ci
|
ATE346050T1
(de)
|
1998-01-27 |
2006-12-15 |
Aventis Pharma Inc |
Substituierte oxoazaheterocyclyl faktor xa hemmer
|
WO1999040072A1
(de)
|
1998-02-03 |
1999-08-12 |
Boehringer Ingelheim Pharma Kg |
5-gliedrige benzokondensierte heterocyclen als antithrombotika
|
AU2298899A
(en)
|
1998-02-05 |
1999-08-23 |
Takeda Chemical Industries Ltd. |
Sulfonamide derivatives, process for producing the same and utilization thereof
|
JP2000204081A
(ja)
|
1998-02-05 |
2000-07-25 |
Takeda Chem Ind Ltd |
スルホンアミド誘導体、その製造法及び用途
|
EP0937711A1
(de)
|
1998-02-18 |
1999-08-25 |
Roche Diagnostics GmbH |
Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
|
EP0937723A1
(de)
|
1998-02-18 |
1999-08-25 |
Roche Diagnostics GmbH |
Neue Sulfonamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
|
WO1999047503A1
(fr)
|
1998-03-19 |
1999-09-23 |
Ajinomoto Co., Inc. |
Derives d'aminoisoquinoleine
|
CA2325471C
(en)
|
1998-03-23 |
2010-08-17 |
Aventis Pharmaceuticals Products Inc. |
Piperididinyl and n-amidinopiperidinyl derivatives
|
ES2230841T3
(es)
|
1998-03-27 |
2005-05-01 |
Bristol-Myers Squibb Pharma Company |
Pirazolinas y triazolinas disustituidas como inhibidores del factor xa.
|
JP2002509923A
(ja)
|
1998-03-31 |
2002-04-02 |
ワーナー−ランバート・カンパニー |
Xa因子およびトロンビンのようなセリンプロテアーゼ阻害剤としてのキノキサリノン
|
US6509335B1
(en)
|
1998-03-31 |
2003-01-21 |
Warner-Lambert Company |
Benzoxazinoes/benzothiazinones as serine protease inhibitors
|
BR9815786A
(pt)
|
1998-03-31 |
2000-11-21 |
Warner Lambert Co |
Quinolonas como inibidores de protease de serina
|
US6344486B1
(en)
|
1998-04-03 |
2002-02-05 |
3-Dimensional Pharmaceuticals, Inc. |
Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
|
US20020061842A1
(en)
|
1998-04-10 |
2002-05-23 |
Octapharma Ag |
Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses
|
KR100416111B1
(ko)
|
1998-04-10 |
2004-01-31 |
니뽄 다바코 산교 가부시키가이샤 |
아미딘 화합물
|
US6417161B1
(en)
|
1998-04-24 |
2002-07-09 |
3-Dimensional Pharmaceuticals, Inc. |
Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
|
DE19819548A1
(de)
|
1998-04-30 |
1999-11-04 |
Merck Patent Gmbh |
Biphenylderivate
|
GB9809349D0
(en)
|
1998-05-02 |
1998-07-01 |
Zeneca Ltd |
Heterocyclic derivatives
|
GB9809350D0
(en)
|
1998-05-02 |
1998-07-01 |
Zeneca Ltd |
Novel salt
|
PL343706A1
(en)
|
1998-05-02 |
2001-08-27 |
Astrazeneca Ab |
Heterocyclic derivatives which inhibit factor xa
|
WO1999064392A1
(fr)
|
1998-06-08 |
1999-12-16 |
Ajinomoto Co., Inc. |
Derive de benzamidine
|
DE69926884T2
(de)
|
1998-06-11 |
2006-06-14 |
Johnson & Johnson Pharm Res |
Pyrazine protease inhibitore
|
DE19829964A1
(de)
|
1998-07-04 |
2000-01-05 |
Boehringer Ingelheim Pharma |
Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
|
TWI248435B
(en)
|
1998-07-04 |
2006-02-01 |
Boehringer Ingelheim Pharma |
Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
|
DE19834751A1
(de)
|
1998-08-01 |
2000-02-03 |
Boehringer Ingelheim Pharma |
Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
|
DE19835950A1
(de)
|
1998-08-08 |
2000-02-10 |
Merck Patent Gmbh |
Piperazinonderivate
|
US6747023B1
(en)
|
1998-08-11 |
2004-06-08 |
Daiichi Pharmaceutical Co., Ltd. |
Sulfonyl derivatives
|
JP2000143623A
(ja)
|
1998-08-28 |
2000-05-26 |
Dai Ichi Seiyaku Co Ltd |
新規なスルホニル誘導体およびその塩
|
DE19839499A1
(de)
|
1998-08-29 |
2000-03-02 |
Merck Patent Gmbh |
2-Oxo-2H-chinolinderivate
|
SE9802938D0
(sv)
|
1998-09-01 |
1998-09-01 |
Astra Ab |
Improved stability for injection solutions
|
JP2000080046A
(ja)
|
1998-09-03 |
2000-03-21 |
Dai Ichi Seiyaku Co Ltd |
多臓器障害の予防・治療剤
|
SE9802973D0
(sv)
|
1998-09-03 |
1998-09-03 |
Astra Ab |
Immediate release tablet
|
DE19845153A1
(de)
|
1998-10-01 |
2000-04-06 |
Merck Patent Gmbh |
Imidazo[4,5]-pyridin-4-on-derivate
|
TW575567B
(en)
|
1998-10-23 |
2004-02-11 |
Akzo Nobel Nv |
Serine protease inhibitor
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
JP2003529531A
(ja)
|
1998-11-25 |
2003-10-07 |
アヴェンティス ファーマシューティカルズ インコーポレイテッド |
置換オキソアザへテロシクリルXa因子阻害剤
|
US6127376A
(en)
|
1998-12-04 |
2000-10-03 |
Berlex Laboratories, Inc. |
Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
|
JP2000178243A
(ja)
|
1998-12-14 |
2000-06-27 |
Teijin Ltd |
ビフェニルアミジン誘導体
|
JP3827530B2
(ja)
|
1998-12-16 |
2006-09-27 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
置換アリール誘導体及び置換ヘテロアリール誘導体、それらの調製及び薬物としてのそれらの使用
|
HUP0104987A3
(en)
*
|
1998-12-18 |
2002-09-30 |
Axys Pharmaceuticals Inc South |
Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
|
AU2381600A
(en)
|
1998-12-23 |
2000-07-31 |
Du Pont Pharmaceuticals Company |
Thrombin or factor xa inhibitors
|
ES2226485T3
(es)
|
1998-12-23 |
2005-03-16 |
Eli Lilly And Company |
Amidas aromaticas.
|
WO2000039117A1
(en)
|
1998-12-23 |
2000-07-06 |
Eli Lilly And Company |
HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa
|
ES2232202T3
(es)
|
1998-12-23 |
2005-05-16 |
Bristol-Myers Squibb Pharma Company |
Heterobiciclos que contienen nitrogeno como inhibidores del factor xa.
|
US6610704B1
(en)
|
1998-12-23 |
2003-08-26 |
Eli Lilly And Company |
Antithrombotic amides
|
ATE261941T1
(de)
|
1998-12-24 |
2004-04-15 |
Lilly Co Eli |
Heterocyclische amide als inhibitoren von faktor xa
|
EP1140901A2
(en)
|
1998-12-24 |
2001-10-10 |
Aventis Pharmaceuticals Products Inc. |
Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
|
AU2844800A
(en)
|
1998-12-30 |
2000-07-24 |
Aventis Pharmaceuticals Products Inc. |
Process for preparing a stable non-hygroscopic crystalline n-(n-(n- piperdin- 4-yl)butanoyl)- n.ethylglycyl)- (l)-aspartyl) -ss-cyclohexylalanine amide
|
EP1016663A1
(en)
|
1999-01-02 |
2000-07-05 |
Aventis Pharma Deutschland GmbH |
Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
|
CA2358581C
(en)
|
1999-01-02 |
2010-02-02 |
Aventis Pharma Deutschland Gmbh |
Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
|
CA2358578A1
(en)
|
1999-01-02 |
2000-07-13 |
Aventis Pharma Deutschland Gmbh |
Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity)
|
DE19900355A1
(de)
|
1999-01-07 |
2000-07-13 |
Merck Patent Gmbh |
Benzimidazolderivate
|
DE19900471A1
(de)
|
1999-01-08 |
2000-07-13 |
Merck Patent Gmbh |
Imidazo[4,5c]-pyridin-4-on-derivate
|
SK11422001A3
(sk)
|
1999-02-09 |
2002-04-04 |
3-Dimensional Pharmaceuticals Inc. |
Heteroarylamidíny, metylamidíny a guanidíny ako inhibítory proteázy
|
WO2000047207A1
(en)
|
1999-02-09 |
2000-08-17 |
Bristol-Myers Squibb Company |
LACTAM INHIBITORS OF FXa AND METHOD
|
AU756174B2
(en)
|
1999-02-09 |
2003-01-09 |
Bristol-Myers Squibb Company |
Lactam inhibitors of FXa and method
|
GB9902989D0
(en)
|
1999-02-11 |
1999-03-31 |
Zeneca Ltd |
Heterocyclic derivatives
|
AU3857300A
(en)
|
1999-02-11 |
2000-08-29 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
DE19909237A1
(de)
|
1999-03-03 |
2000-09-07 |
Merck Patent Gmbh |
Pyrazol-3-on-derivate
|
CN1346292A
(zh)
|
1999-03-11 |
2002-04-24 |
杜邦药品公司 |
凝血因子Xa抑制剂与阿司匹林、组织纤溶酶原激活物(TPA)、GPⅡb/Ⅲa拮抗剂、低分子量肝素或肝素联合用于治疗血栓形成
|
AU3329400A
(en)
|
1999-03-31 |
2000-10-23 |
Kissei Pharmaceutical Co. Ltd. |
3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
ES2197092T3
(es)
|
1999-04-02 |
2004-01-01 |
Bristol-Myers Squibb Pharma Company |
Sulfonil arilos como inhibidores del factor xa.
|
JP4390024B2
(ja)
|
1999-04-23 |
2009-12-24 |
アステラス製薬株式会社 |
新規なジアゼパン誘導体又はその塩
|
US6545055B1
(en)
|
1999-05-24 |
2003-04-08 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
AU5283600A
(en)
|
1999-05-24 |
2000-12-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
JP2003500387A
(ja)
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Xa因子の阻害剤
|
US6638980B1
(en)
|
1999-05-24 |
2003-10-28 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
AU5546000A
(en)
|
1999-06-14 |
2001-01-02 |
Protherics Molecular Design Limited |
Compounds
|
EP1192132B1
(en)
|
1999-06-14 |
2005-09-07 |
Eli Lilly And Company |
Serine protease inhibitors
|
GB9914342D0
(en)
|
1999-06-19 |
1999-08-18 |
Zeneca Ltd |
Compound
|
CA2383492A1
(en)
|
1999-06-22 |
2000-12-28 |
Takeda Chemical Industries, Ltd. |
Acylhydrazine derivatives, their production and use
|
WO2001002397A1
(fr)
|
1999-06-30 |
2001-01-11 |
Mochida Pharmaceutical Co., Ltd. |
Composes tricycliques presentant une jonction spiro
|
WO2001002356A1
(fr)
|
1999-07-01 |
2001-01-11 |
Sankyo Company, Limited |
Dérivés d'indoline ou tétrahydroquinoline
|
JP2004507439A
(ja)
|
1999-07-16 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
Xa因子阻害剤としての窒素含有ヘテロ二環式化合物
|
US6350761B1
(en)
|
1999-07-30 |
2002-02-26 |
Berlex Laboratories, Inc. |
Benzenamine derivatives as anti-coagulants
|
AU6762400A
(en)
|
1999-08-12 |
2001-03-13 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
US6469029B1
(en)
|
1999-09-13 |
2002-10-22 |
3-Dimensional Pharmaceuticals, Inc. |
Azacycloalkanone serine protease inhibitors
|
MX226123B
(es)
|
1999-09-17 |
2005-02-07 |
Millennium Pharm Inc |
Benzamidas e inhibidores del factor xa relacionadas.
|
CA2385589A1
(en)
|
1999-09-17 |
2001-03-22 |
Bing-Yan Zhu |
Inhibitors of factor xa
|
JP2003515560A
(ja)
|
1999-12-06 |
2003-05-07 |
スミスクライン・ビーチャム・コーポレイション |
トロンボポイエチン模倣物
|
AU2001234705A1
(en)
|
2000-02-01 |
2001-08-14 |
Cor Therapeutics, Inc. |
Indalone and benzimidazolone inhibitors of factor xa
|
US20020065303A1
(en)
|
2000-02-01 |
2002-05-30 |
Bing-Yan Zhu |
Bivalent phenylene inhibitors of factor Xa
|
US20020013314A1
(en)
|
2000-02-01 |
2002-01-31 |
Bing-Yan Zhu |
3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa
|
US6777413B2
(en)
|
2000-02-01 |
2004-08-17 |
Millennium Pharmaceuticals, Inc. |
2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa
|
AU2001245353A1
(en)
|
2000-02-29 |
2001-09-12 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
WO2001072708A2
(en)
|
2000-03-24 |
2001-10-04 |
Cor Therapeutics, Inc. |
OXINDOLE INHIBITORS OF FACTOR Xa
|
US20020019394A1
(en)
|
2000-03-24 |
2002-02-14 |
Wenhao Li |
Bicyclic sulfonyl amino inhibitors of factor Xa
|
US6469026B2
(en)
|
2000-03-24 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Isoquinolone inhibitors of factor Xa
|
US20020037912A1
(en)
*
|
2000-08-11 |
2002-03-28 |
Leahy Ellen M. |
Factor viia inhibitors
|
US6465503B2
(en)
|
2000-08-11 |
2002-10-15 |
Axys Pharmaceuticals, Inc. |
Selective urokinase inhibitors
|
CA2421548C
(en)
|
2000-09-11 |
2007-10-30 |
Genentech, Inc. |
Amidine inhibitors of serine proteases
|
CA2452391A1
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
KR20040065278A
(ko)
|
2001-12-21 |
2004-07-21 |
노보 노르디스크 에이/에스 |
변경된 인자 ⅶ 폴리펩티드의 액체 조성물
|
WO2003068756A1
(en)
|
2002-02-13 |
2003-08-21 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
|
MXPA04009703A
(es)
|
2002-04-08 |
2004-12-13 |
Guilford Pharm Inc |
Composiciones farmaceuticas que contienen promedicamentos solubles en agua de propofol y metodoss para administrar los mismos.
|
WO2004050637A2
(en)
|
2002-12-03 |
2004-06-17 |
Axys Pharmaceuticals, Inc. |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
|
AU2003300106A1
(en)
|
2003-01-08 |
2004-08-10 |
Axys Pharmaceuticals, Inc. |
2-'5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl!- carboxylic acid derivatives as factor viia inhibitors
|
US8729117B2
(en)
|
2004-06-02 |
2014-05-20 |
Pharmacyclics, Inc. |
Factor VIIa inhibitor
|
EP1761504A2
(en)
|
2004-06-02 |
2007-03-14 |
Pharmacyclics, Inc. |
Factor viia inhibitor
|
JP2008501702A
(ja)
|
2004-06-02 |
2008-01-24 |
ファーマサイクリックス,インコーポレイティド |
第VIIa因子阻害剤
|
US8552046B2
(en)
|
2007-10-16 |
2013-10-08 |
Pharmacyclics, Inc. |
Manufacture, compositions and uses of coagulation factor VIIa modulator
|